Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14508
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAsasutjarit R.
dc.contributor.authorThanasanchokpibull S.
dc.contributor.authorFuongfuchat A.
dc.contributor.authorVeeranondha S.
dc.date.accessioned2021-04-05T03:35:14Z-
dc.date.available2021-04-05T03:35:14Z-
dc.date.issued2011
dc.identifier.issn3785173
dc.identifier.other2-s2.0-79955964137
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14508-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-79955964137&doi=10.1016%2fj.ijpharm.2011.03.054&partnerID=40&md5=e6796a020ba5dd296f3ed09e332ccf9f
dc.description.abstractThis work was conducted to optimize and evaluate Pluronic F127-based thermoresponsive diclofenac sodium ophthalmic in situ gels (DS in situ gel). They were prepared by cold method and investigated their physicochemical properties i.e., pH, flow ability, sol-gel transition temperature, gelling capacity and rheological properties. An optimized formulation was selected and investigated its physicochemical properties before and after autoclaving, eye irritation potency in SIRC cells and rabbits. In vivo ophthalmic absorption was performed in rabbits. It was found that physicochemical properties of DS in situ gels were affected by formulation compositions. Increment of Pluronic F127 content decreased sol-gel transition temperature of the products while increase in Pluronic F68 concentration tended to increase sol-gel transition temperature. In this study, Carbopol 940 did not affect sol-gel transition temperature but it affected transparency, pH, and gelling capacity of the products. The optimized formulation exhibited sol-gel transition at 32.6 ± 1.1°C with pseudoplastic flow behavior. It was lost diclofenac sodium content during autoclaving. However, it was accepted as safe for ophthalmic use and could increase diclofenac sodium bioavailability in aqueous humor significantly. In conclusion, the optimized DS in situ gel had potential for using as an alternative to the conventional diclofenac sodium eye drop. However, autoclaving was not a suitable sterilization method for this product. © 2011 Elsevier B.V. All rights reserved.
dc.subjectbenzalkonium chloride
dc.subjectcarbopol 940
dc.subjectdiclofenac
dc.subjectpoloxamer
dc.subjectanimal cell
dc.subjectanimal experiment
dc.subjectaqueous humor
dc.subjectarticle
dc.subjectautoclave
dc.subjectcontrolled study
dc.subjectdrug absorption
dc.subjectdrug bioavailability
dc.subjectdrug formulation
dc.subjecteye irritation
dc.subjectfemale
dc.subjectflow kinetics
dc.subjectgel
dc.subjectin vivo study
dc.subjectmale
dc.subjectnonhuman
dc.subjectpH
dc.subjectpriority journal
dc.subjectrabbit
dc.subjectshear flow
dc.subjecttransition temperature
dc.subjectAcrylic Resins
dc.subjectAdministration, Ophthalmic
dc.subjectAnimals
dc.subjectAnti-Inflammatory Agents, Non-Steroidal
dc.subjectAqueous Humor
dc.subjectDiclofenac
dc.subjectDrug Administration Routes
dc.subjectDrug Compounding
dc.subjectDrug Delivery Systems
dc.subjectExcipients
dc.subjectEye
dc.subjectGels
dc.subjectHot Temperature
dc.subjectMale
dc.subjectOphthalmic Solutions
dc.subjectPhase Transition
dc.subjectPhysicochemical Phenomena
dc.subjectPoloxamer
dc.subjectRabbits
dc.subjectSterilization
dc.subjectTransition Temperature
dc.titleOptimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationInternational Journal of Pharmaceutics. Vol 411, (2011), p.128-135
dc.identifier.doi10.1016/j.ijpharm.2011.03.054
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.